During the past decade, Saint Jude Midwest Affiliate conducted 65 clinical trials. In the 10-year time frame, 65 clinical trials started and 62 clinical trials were completed, i.e. on average, 95.4% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 28 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Jude Midwest Affiliate" #1 sponsor was "Children's Oncology Group" with 119 trials, followed by "National Cancer Institute (NCI)" with 53 trials sponsored, "Eisai Inc." with 1 trials sponsored, "LLS PedAL Initiative, LLC" with 1 trials sponsored and "SWOG Cancer Research Network" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Jude Midwest Affiliate" #1 collaborator was "National Cancer Institute (NCI)" with 122 trials as a collaborator, "Children's Oncology Group" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "Children's Cancer and Leukaemia Group" with 1 trials as a collaborator and "EBMT Solid Tumors Working Party" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Saint Jude Midwest Affiliate" are "Recurrent Neuroblastoma" (22 trials), "Recurrent Osteosarcoma" (18 trials), "Refractory Neuroblastoma" (15 trials), "Leukemia" (14 trials) and "Refractory Non-Hodgkin Lymphoma" (14 trials). Many other conditions were trialed in "Saint Jude Midwest Affiliate" in a lesser frequency.

Most popular intervention types in "Saint Jude Midwest Affiliate" are "Drug" (139 trials), "Other" (89 trials), "Procedure" (66 trials), "Biological" (65 trials) and "Radiation" (56 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (54 trials), "Cyclophosphamide" (37 trials), "Vincristine Sulfate" (30 trials), "Doxorubicin Hydrochloride" (26 trials) and "Etoposide" (26 trials). Other intervention names were less common.

The vast majority of trials in "Saint Jude Midwest Affiliate" are 176 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Jude Midwest Affiliate". undefined are not yet recruiting, 37 are recruiting, 55 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 80 completed trials in Saint Jude Midwest Affiliate, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Jude Midwest Affiliate, 11 "Phase 1" clinical trials were conducted, 77 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".